As of June 10, 2025, AVROBIO Inc (AVRO) reports a Graham Number of 3.59.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Historical Trend of AVROBIO Inc's Graham Number
Over recent years, AVROBIO Inc's Graham Number has shown limited historical data. The table below summarizes the historical values:
| Date | Graham Number |
|---|---|
| 2023-12-31 | 3.59 |
| 2022-12-31 | 15.42 |
This trend highlights how AVROBIO Inc manages its intrinsic value calculation based on earnings per share and book value over time.
Comparing AVROBIO Inc's Graham Number to Peers
To better understand AVROBIO Inc's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| AVROBIO Inc (AVRO) | 3.59 |
| Regeneron Pharmaceuticals Inc (REGN) | 500.00 |
| Moderna Inc (MRNA) | 157.32 |
| Vertex Pharmaceuticals Inc (VRTX) | 146.93 |
| Amgen Inc (AMGN) | 43.25 |
| Oyster Point Pharma Inc (OYST) | 17.80 |
Compared to its competitors, AVROBIO Inc's Graham Number is about average compared to peers, reflecting standard fundamental metrics for the industry.